Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle

Premenstrual dysphoric disorder (PMDD) is a severe mood disorder with core symptoms (affective lability, irritability, depressed mood, anxiety) and increased sensitivity to stress occurring in the luteal phase of the menstrual cycle. PMDD can be conceptualized as a disorder of suboptimal sensitivity...

Descripción completa

Detalles Bibliográficos
Autores principales: Hantsoo, Liisa, Epperson, C. Neill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Articles from the Special Issue on Allopregnanolone role in the neurobiology of stress and mood disorders; Edited by Graziano Pinna
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231988/
https://www.ncbi.nlm.nih.gov/pubmed/32435664
http://dx.doi.org/10.1016/j.ynstr.2020.100213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231988/
https://www.ncbi.nlm.nih.gov/pubmed/32435664
http://dx.doi.org/10.1016/j.ynstr.2020.100213

Ejemplares similares